MARKET

CSTL

CSTL

Castle Biosciences
NASDAQ
39.66
+0.61
+1.56%
Closed 17:38 12/17 EST
OPEN
39.05
PREV CLOSE
39.05
HIGH
40.10
LOW
38.16
VOLUME
319.84K
TURNOVER
0
52 WEEK HIGH
40.61
52 WEEK LOW
14.59
MARKET CAP
1.16B
P/E (TTM)
-87.5110
1D
5D
1M
3M
1Y
5Y
1D
Castle Biosciences CEO Derek J. Maetzold Reports Sale of Common Shares
Reuters · 15h ago
GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment
NASDAQ · 21h ago
FDA Grants Fast Track Designation to ADAG's Colorectal Cancer Drug
NASDAQ · 23h ago
Castle Biosciences Study Finds DecisionDx-UM Plus PRAME Outperforms Gene Mutation Analysis in Uveal Melanoma Prognosis
Reuters · 1d ago
Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
Barchart · 1d ago
AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer
NASDAQ · 1d ago
KYTX Stock Rallies 23% on Upbeat Stiff Person Syndrome Study Data
NASDAQ · 1d ago
Castle Biosciences Executives Make Significant Stock Sales!
TipRanks · 2d ago
More
About CSTL
Castle Biosciences, Inc. is a molecular diagnostics company offering test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma (UM), and in the treatment of mental health conditions. The Company offers five commercially available proprietary multi-analyte assays with algorithmic analysis (MAAA) tests for use in the fields of dermatology, gastroenterology and ophthalmology. It also offers a proprietary pharmacogenomic (PGx) test to guide optimal drug treatment for patients diagnosed with depression, anxiety and other mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-SCC is its proprietary gene expression profile (GEP) test for use in patients with cutaneous squamous cell carcinoma (SCC). It also focused on chronic acid reflux related diseases, including esophageal cancer.

Webull offers Castle Biosciences Inc stock information, including NASDAQ: CSTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSTL stock methods without spending real money on the virtual paper trading platform.